Imiglucerase
In the US, Imiglucerase (imiglucerase systemic) is a member of the drug class lysosomal enzymes and is used to treat Gaucher Disease and Thrombocytopenia.
US matches:
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
A16AB02
CAS registry number (Chemical Abstracts Service)
0154248-97-2
Chemical Formula
C2532-H3843-N671-O711-S16
Molecular Weight
55575
Therapeutic Category
Enzyme replacement therapy
Chemical Names
495-L-Histidineglucosylceramidase (human placenta isoenzyme protein moiety)
Recombinant human acid beta-glucocerebrosidase
Foreign Names
- Imiglucerasum (Latin)
- Imiglucerase (German)
- Imiglucérase (French)
- Imiglucerasa (Spanish)
Generic Names
- Imiglucerase (OS: USAN, BAN)
- Imiglucérase (OS: DCF)
- Alglucerase, gentechnisch hergestellt (IS)
Brand Names
- Cerezyme
Genzyme, Austria; Genzyme, Australia; Genzyme, Bosnia & Herzegowina; Genzyme, Belgium; Genzyme, Canada; Genzyme, Chile; Genzyme, China; Genzyme, Czech Republic; Genzyme, Germany; Genzyme, Denmark; Genzyme, Spain; Genzyme, Finland; Genzyme, France; Genzyme, United Kingdom; Genzyme, Greece; Genzyme, Hong Kong; Genzyme, Israel; Genzyme, Italy; Genzyme, Lithuania; Genzyme, Luxembourg; Genzyme, Latvia; Genzyme, Netherlands; Genzyme, Norway; Genzyme, New Zealand; Genzyme, Romania; Genzyme, Serbia; Genzyme, Sweden; Genzyme, Slovenia; Genzyme, Slovakia; Genzyme, Turkey; Genzyme, Taiwan; Genzyme, United States; Genzyme Europe, Poland; Genzyme Nippon, Japan; Medical Intertrade, Croatia (Hrvatska); Sam Oh, South Korea; Sanofi-Aventis, Switzerland
International Drug Name Search
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
